Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

Intravenous ibandronate injections in po

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study

✍ Pierre D. Delmas; Silvano Adami; Cezary Strugala; Jacob A. Stakkestad; Jean-Yves 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract ## Objective Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patients. Ibandronate, a potent nitroge